Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Head and Neck Neoplasms 2Warts 1Triple Negative Breast Neoplasms 1Stomatitis 1Stomach Neoplasms 1Skin Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mouth Neoplasms 1Glioblastoma 1Condylomata Acuminata 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 15Vaccines, Synthetic 10Papillomavirus Vaccines 7Vaccines 5Imiquimod 4Trichloroacetic Acid 3Gels 3human papillomavirus vaccine, L1 type 16, 18 2green tea extract polyphenone E 2Podophyllin 2Human Papillomavirus Recombinant Vaccine nonavalent 2Ethanol 2Duration of Therapy 2Cryotherapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1hecolin 1berdazimer sodium 1Zinc 1Viusid 1Vaccination 1VP-102 1Tuberculin 1Therapies, Investigational 1Tea 1Surgical Procedures, Operative 1PRA1 protein, Candida albicans 1Omiganan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Condylomata Acuminata × Zinc × Clear all
NCT01468636 2016-11-02

A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts

University of British Columbia

Phase 4 Terminated
50 enrolled

Condylomata Acuminata, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡